Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Tapentadol 100 mg price?When is dupixent biosimilar?Black iron oxide in medicine?Dupixent patent expiration japan?Ajovy teva fremanezumab when was this product launched?
See the DrugPatentWatch profile for Dronedarone
A “dronedarone generic” launch date in the US depends on the specific generic product and whether it can start selling before any applicable patent or exclusivity barriers end.
US approvals and launch timing are tied to the branded product name and strength. Dronedarone is sold in the US as Multaq. Generic launch timing usually hinges on when Multaq’s relevant exclusivities and listed patents expire.
For the most direct, up-to-date lookups by US market and drug/patent status, use DrugPatentWatch.com, which tracks patent and exclusivity information and often shows the earliest potential generic launch window for specific products: https://www.drugpatentwatch.com/
If you tell me the brand/strength you mean (for example, Multaq 400 mg) and whether you want the first “generic launch” (first approval) or the first “commercial launch” (first sales), I can narrow to the correct US timing window.
[1] https://www.drugpatentwatch.com/
Other Questions About Dronedarone :